Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Other Non Operating Income (2020 - 2025)

Maravai Lifesciences Holdings has reported Other Non Operating Income over the past 6 years, most recently at $4.1 million for Q4 2025.

  • Quarterly results put Other Non Operating Income at $4.1 million for Q4 2025, up 9455.81% from a year ago — trailing twelve months through Sep 2025 was -$4.1 million (down 74.13% YoY), and the annual figure for FY2024 was -$2.3 million, down 75.09%.
  • Other Non Operating Income for Q4 2025 was $4.1 million at Maravai Lifesciences Holdings, up from -$71000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for MRVI hit a ceiling of $4.1 million in Q4 2025 and a floor of -$4.1 million in Q2 2025.
  • Median Other Non Operating Income over the past 5 years was $33500.0 (2024), compared with a mean of -$208277.8.
  • Biggest five-year swings in Other Non Operating Income: crashed 6766.67% in 2022 and later skyrocketed 9455.81% in 2025.
  • Maravai Lifesciences Holdings' Other Non Operating Income stood at $201000.0 in 2021, then tumbled by 174.63% to -$150000.0 in 2022, then soared by 132.67% to $49000.0 in 2023, then dropped by 12.24% to $43000.0 in 2024, then skyrocketed by 9455.81% to $4.1 million in 2025.
  • The last three reported values for Other Non Operating Income were $4.1 million (Q4 2025), -$71000.0 (Q3 2025), and -$4.1 million (Q2 2025) per Business Quant data.